Clinical Trial Update: Magnesium Prophylaxis for the Prevention of New-Onset Atrial Fibrillation in Critically Ill Patients [Phase 4]

View source ↗

Summary

Phase 4 study evaluating magnesium prophylaxis to prevent new-onset atrial fibrillation in critically ill patients; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Magnesium sulfate (magnesium sulfate)

Snippet

Sponsor: Dr. Stephanie Sibley | Conditions: Critical Illness, New Onset Atrial Fibrillation | Phase 4 | Status: RECRUITING